Skip to content
10-Q

Quarterly Report

Cell Source, Inc. CLCS

0001493152-22-034255

← back to feed
Filed
Dec 2, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Nov 30, 2022 35.25M sh
Cash And Equivalents Q2 2022 · Jun 30, 2022 $2.6K
Cash And Equivalents Q2 2022 · Dec 31, 2021 $93.1K
Total Liabilities Q2 2022 · Jun 30, 2022 $10.81M
Total Liabilities Q2 2022 · Dec 31, 2021 $10.14M
Total Assets Q2 2022 · Jun 30, 2022 $44.64K
Total Assets Q2 2022 · Dec 31, 2021 $313.77K
Rd Expense Q2 2022 · Jun 30, 2022 $555.01K
Rd Expense Q2 2022 · Jun 30, 2022 $1.02M
Rd Expense Q2 2022 · Jun 30, 2021 $355.05K
Rd Expense Q2 2022 · Jun 30, 2021 $590.82K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$2.26M
Stockholders Equity Q2 2022 · Jun 30, 2021 −$10.03M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$9.04M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$7.95M
Eps Basic Q2 2022 · Jun 30, 2021 −$0.05
Eps Basic Q2 2022 · Jun 30, 2021 −$0.10
Net Income Q2 2022 · Jun 30, 2021 −$1.31M
Net Income Q2 2022 · Jun 30, 2021 −$2.84M
Operating Income Q2 2022 · Jun 30, 2021 −$995.1K
Operating Income Q2 2022 · Jun 30, 2021 −$2.12M